FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200261053> ?p ?o ?g. }

• W4200261053 endingPage "77" @default.
• W4200261053 startingPage "77" @default.
• W4200261053 abstract "In 2017, the Swedish Environmental Protection Agency published a report on advanced wastewater treatment for the removal of pharmaceutical residues and stated that advanced treatment should be implemented where it will make the largest difference from an environmental perspective. However, the report also concluded that this need cannot be specified with existing data, but consideration must be made of local conditions. Two considerations are (1) the discharged amount of pharmaceutical into receiving water bodies and (2) the turnover of water in the recipient, where the highest risks are related to recipients with a low water turnover and low dilution. The current project comprised eight different WWTPs distributed throughout the entire County Skåne (Scania) in Sweden, with a population of ca. 1,300,000 persons. In total, 21 of 22 pharmaceuticals were analyzed according to the list proposed by the Swedish Medical Products Agency 2015. The results show that large amounts of pharmaceuticals are released from the WWTPs yearly to Scanian recipients. The total discharge of pharmaceuticals from the eight treatment plants adds up to 71 kg of these 21 substances alone, mainly comprising metoprolol, which is a drug that lowers blood pressure, and the analgesic drug diclofenac. Additionally, carbamazepine, losartan, naproxen and oxazepam were present in significant concentrations. These represented three illnesses that are very common: high blood pressure, inflammation/pain and depression/anxiety. The concentrations were generally in line with previous national Swedish screenings. It was estimated that, when one million cubic meters (1,000,000 m3) of wastewater is discharged, almost 4 kg of the 21 pharmaceuticals is released. The total volume wastewater release by the >90 WWTPs in Scania was estimated to 152,887,000 m3, which corresponded to 590 kg/year. The investigated 21 drugs cover only a small part of many hundred pharmaceuticals that are in use in Sweden. Thus, most likely, one or several tons of pharmaceuticals leak out to the Scanian recipients annually. The analysis of river samples shows that the dilution of wastewater is a key parameter in reducing concentrations. However, some locations have remarkably high concentrations, which occur when the volume wastewater is large in relation to the flow in the river. These kinds of regional results are of importance when selecting where advanced treatment should be prioritized in a first instance, as requested by the Swedish EPA." @default.
• W4200261053 created "2021-12-31" @default.
• W4200261053 creator A5050577274 @default.
• W4200261053 creator A5082902520 @default.
• W4200261053 date "2021-12-23" @default.
• W4200261053 modified "2023-09-25" @default.
• W4200261053 title "Total Release of 21 Indicator Pharmaceuticals Listed by the Swedish Medical Products Agency from Wastewater Treatment Plants to Surface Water Bodies in the 1.3 Million Populated County Skåne (Scania), Sweden" @default.
• W4200261053 cites W1185542290 @default.
• W4200261053 cites W1868142102 @default.
• W4200261053 cites W1965064785 @default.
• W4200261053 cites W1968316487 @default.
• W4200261053 cites W1992469146 @default.
• W4200261053 cites W1995825006 @default.
• W4200261053 cites W2008650582 @default.
• W4200261053 cites W2020802278 @default.
• W4200261053 cites W2024495965 @default.
• W4200261053 cites W2025530120 @default.
• W4200261053 cites W2035689300 @default.
• W4200261053 cites W2038000605 @default.
• W4200261053 cites W2048407248 @default.
• W4200261053 cites W2049276422 @default.
• W4200261053 cites W2049539640 @default.
• W4200261053 cites W2052359006 @default.
• W4200261053 cites W2054688636 @default.
• W4200261053 cites W2056913884 @default.
• W4200261053 cites W2059201410 @default.
• W4200261053 cites W2068609617 @default.
• W4200261053 cites W2072731742 @default.
• W4200261053 cites W2074807955 @default.
• W4200261053 cites W2094482270 @default.
• W4200261053 cites W2146356156 @default.
• W4200261053 cites W2162198950 @default.
• W4200261053 cites W2178998801 @default.
• W4200261053 cites W2297938101 @default.
• W4200261053 cites W2340344856 @default.
• W4200261053 cites W2346246800 @default.
• W4200261053 cites W239904280 @default.
• W4200261053 cites W2496723117 @default.
• W4200261053 cites W2498640245 @default.
• W4200261053 cites W2514139663 @default.
• W4200261053 cites W2591737767 @default.
• W4200261053 cites W2594678301 @default.
• W4200261053 cites W2621379926 @default.
• W4200261053 cites W2728670048 @default.
• W4200261053 cites W2749563286 @default.
• W4200261053 cites W2766270740 @default.
• W4200261053 cites W2792868632 @default.
• W4200261053 cites W2795372243 @default.
• W4200261053 cites W2804773906 @default.
• W4200261053 cites W2883783287 @default.
• W4200261053 cites W2888413644 @default.
• W4200261053 cites W2938374935 @default.
• W4200261053 cites W3002350232 @default.
• W4200261053 cites W3003347613 @default.
• W4200261053 cites W3033533426 @default.
• W4200261053 cites W3034860407 @default.
• W4200261053 cites W3045659889 @default.
• W4200261053 doi "https://doi.org/10.3390/molecules27010077" @default.
• W4200261053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35011310" @default.
• W4200261053 hasPublicationYear "2021" @default.
• W4200261053 type Work @default.
• W4200261053 citedByCount "3" @default.
• W4200261053 countsByYear W42002610532022 @default.
• W4200261053 crossrefType "journal-article" @default.
• W4200261053 hasAuthorship W4200261053A5050577274 @default.
• W4200261053 hasAuthorship W4200261053A5082902520 @default.
• W4200261053 hasBestOaLocation W42002610531 @default.
• W4200261053 hasConcept C126322002 @default.
• W4200261053 hasConcept C147455438 @default.
• W4200261053 hasConcept C170493617 @default.
• W4200261053 hasConcept C2778173252 @default.
• W4200261053 hasConcept C2778519950 @default.
• W4200261053 hasConcept C2908647359 @default.
• W4200261053 hasConcept C39432304 @default.
• W4200261053 hasConcept C71924100 @default.
• W4200261053 hasConcept C87717796 @default.
• W4200261053 hasConcept C94061648 @default.
• W4200261053 hasConcept C99454951 @default.
• W4200261053 hasConceptScore W4200261053C126322002 @default.
• W4200261053 hasConceptScore W4200261053C147455438 @default.
• W4200261053 hasConceptScore W4200261053C170493617 @default.
• W4200261053 hasConceptScore W4200261053C2778173252 @default.
• W4200261053 hasConceptScore W4200261053C2778519950 @default.
• W4200261053 hasConceptScore W4200261053C2908647359 @default.
• W4200261053 hasConceptScore W4200261053C39432304 @default.
• W4200261053 hasConceptScore W4200261053C71924100 @default.
• W4200261053 hasConceptScore W4200261053C87717796 @default.
• W4200261053 hasConceptScore W4200261053C94061648 @default.
• W4200261053 hasConceptScore W4200261053C99454951 @default.
• W4200261053 hasIssue "1" @default.
• W4200261053 hasLocation W42002610531 @default.
• W4200261053 hasLocation W42002610532 @default.
• W4200261053 hasLocation W42002610533 @default.
• W4200261053 hasLocation W42002610534 @default.
• W4200261053 hasOpenAccess W4200261053 @default.
• W4200261053 hasPrimaryLocation W42002610531 @default.
• W4200261053 hasRelatedWork W1977384357 @default.
• W4200261053 hasRelatedWork W2387081153 @default.

• next